Lupus (SLE): nyitott vizsgálatok itt: Dél-Korea

• NCT07332481

  A Study of Enpatoran in Participants With Cutaneous Manifestations of Lupus With or Without Systemic Disease

  Kísérleti kezelés · 3. fázis · EMD Serono Research & Development Institute, Inc.

  Korea University Ansan Hospital - 300133335, Ansan-si · Gachon University Gil Medical Center, Incheon · Seoul National University Bundang Hospital, Seongnam-si · Hanyang University Seoul Hospital - 300186741, Seoul

  Regiszter frissítve: 2026-11-04

• NCT07355218

  A Study of Enpatoran in Participants With Cutaneous Manifestations of Lupus With or Without Systemic Disease (ELOWEN-2)

  Kísérleti kezelés · 3. fázis · EMD Serono Research & Development Institute, Inc.

  Chung-ang University Gwangmyeong Hospital, Seongnam-si · Kyung Hee University Hospital at Gangdong, Seoul · Severance Hospital, Yonsei University Health System - Division of Infectious Diseases, Seoul

  Regiszter frissítve: 2026-11-04

• NCT07438496

  A Study of Nipocalimab in Adults With Moderate to Severe Systemic Lupus Erythematosus

  Kísérleti kezelés · 3. fázis · Janssen Research & Development, LLC

  Dong-A University Hospital, Busan · Chonnam National University Hospital, Gwangju · Seoul National University Bundang Hospital, Gyeonggi-do · Asan Medical Center, Seoul · Seoul National University Hospital, Seoul · Hanyang University Medical Center, Seoul · Ajou University Hospital, Suwon

  Regiszter frissítve: 2026-11-03

• NCT06617325

  A Study to Evaluate the Efficacy and Safety of Dapirolizumab Pegol in Study Participants With Moderately to Severely Active Systemic Lupus Erythematosus

  Kísérleti kezelés · 3. fázis · UCB Biopharma SRL

  Sl0044 20141, Busan · Sl0044 20108, Incheon · Sl0044 20104, Seoul · Sl0044 20351, Seoul · Sl0044 20105, Seoul · Sl0044 20092, Suwon

  Regiszter frissítve: 2026-11-02

• NCT07691970

  Rollover Study for Participants Who Have Completed a Previous Clinical Study With Anifrolumab (Saphnelo) and Clinically Benefited From Continued Treatment

  Kísérleti kezelés · 3. fázis · AstraZeneca

  Seoul

  Regiszter frissítve: 2026-10-28

• NCT06975787

  Dose Escalation Study With Bispecific Antibodies in Adult Participants With Lupus Nephritis

  Kísérleti kezelés · 1. fázis · Regeneron Pharmaceuticals

  Hallym University Sacred Heart Hospital, Anyang-si · Seoul National University Hospital, Seoul · Samsung Medical Center, Seoul · Yonsei University College of Medicine (Severance Hospital), Seoul

  Regiszter frissítve: 2026-10-27

• NCT04976322

  A Study to Evaluate the Safety and Tolerability of Dapirolizumab Pegol in Study Participants With Systemic Lupus Erythematosus

  Kísérleti kezelés · 3. fázis · UCB Biopharma SRL

  Sl0046 20108, Incheon · Sl0046 20104, Seoul

  Regiszter frissítve: 2026-10-15

• NCT06133972

  Phase 3 Extension Study to Evaluate Long-term Safety of Ianalumab in Participants With Systemic Lupus Erythematosus (SIRIUS-SLE Extension).

  Kísérleti kezelés · 3. fázis · Novartis Pharmaceuticals

  Gwangju · Seoul

  Regiszter frissítve: 2026-10-13

• NCT06711887

  Phase III Extension Study of Efficacy and Safety of Ianalumab With or Without Study Treatment Withdrawal in Participants With Lupus Nephritis (SIRIUS-LN Extension)

  Kísérleti kezelés · 3. fázis · Novartis Pharmaceuticals

  Seoul · Suwon

  Regiszter frissítve: 2026-10-13

• NCT05352919

  A Study to Learn More About the Long-Term Safety of Litifilimab (BIIB059) Injections and it's Effects on Symptoms in Adults With Systemic Lupus Erythematosus (SLE)

  Kísérleti kezelés · 3. fázis · Biogen

  Hanyang University Seoul Hospital, Seoul · Ajou University Hospital, Suwon

  Regiszter frissítve: 2026-10-05

• NCT07855302

  CD19 CAR-T Therapy for Refractory Childhood-Onset Systemic Lupus Erythematosus

  Kísérleti kezelés · 1. fázis · Seoul National University Hospital

  Seoul National University Hospital, Seoul

  Regiszter frissítve: 2026-10-02

• NCT07038447

  A Study of KITE-363 in Participants With Refractory Autoimmune Diseases

  Kísérleti kezelés · 1. fázis · Kite, A Gilead Company

  Seoul National University, Seoul · Asan Medical Center, Seoul

  Regiszter frissítve: 2026-09-28

• NCT06475742

  Long-term Safety and Tolerability of Cenerimod in Adults With Systemic Lupus Erythematosus

  Kísérleti kezelés · 3. fázis · Viatris Innovation GmbH

  Seoul National University Hospital, Seoul

  Regiszter frissítve: 2026-09-11

• NCT07515014

  A Study of E6742 in Participants With Systemic Lupus Erythematosus

  Kísérleti kezelés · 2. fázis · Eisai Co., Ltd.

  Daegu Catholic University Medical Center, Daegu · Chonnam National University Hospital, Gwangju

  Regiszter frissítve: 2026-08-21

• NCT07636044

  Reduced Vaccine Response to HZ/su in SLE

  Kutatás · Seoul National University Hospital

  Seoul National University Hospital, Seoul

  Regiszter frissítve: 2026-06-09

• NCT03138941

  Validation of the Lupus Low Disease Activity State (LLDAS) in the Asia Pacific Region

  Kutatás · Monash University

  Department of Rheumatology, Hanyang University Hospital for Rheumatic Diseases, Seoul

  Regiszter frissítve: 2024-12-12

• NCT03929887

  KOrea Renal Biobank NEtwoRk System TOward NExt-generation Analysis

  Kutatás · Seoul National University Hospital

  Kangwon National University Hospital, Chuncheon · Keimyung University - Dongsan Medical Center, Daegu · SMG-SNU Boramae Medical Center, Seoul · Chung-Ang University Hosptial, Seoul · Seoul National University Hospital, Seoul · Severance hospital, Seoul

  Regiszter frissítve: 2020-02-12

Minden vizsgálat (Lupus (SLE)) és a térkép

Ez az oldal nem orvosi tanács. Mielőtt egy vizsgálatot megkeresel, beszélj az orvosoddal.

Hibát jelzek